Tag

Kras Mutation

All articles tagged with #kras mutation

KRAS-targeting drug doubles survival in pancreatic cancer, fueling hope for broader use
health5 days ago

KRAS-targeting drug doubles survival in pancreatic cancer, fueling hope for broader use

Phase 3 results show the KRAS-targeting drug daraxonrasib doubles median survival in advanced pancreatic cancer (13.2 months vs 6.7 with chemotherapy), with FDA fast-track and expanded-access moves under way. The oral drug works by binding the KRAS-driven protein via cyclophilin A and appears less toxic than chemo, prompting optimism about its use in other KRAS-driven cancers, though it is not a cure and researchers are exploring where it fits in treatment sequences.

health3 years ago

"New Vaccine Offers Hope for Treating Deadly Forms of Cancer"

An off-the-shelf cancer vaccine has shown potential to prevent relapse in patients with pancreatic and colon cancer caused by the KRAS mutation, which accounts for up to 90% of the disease. The vaccine uses peptides to bind to the protein albumin, creating white blood cells that help fight off cancer markers present in the patients’ blood. The vaccine was 100% effective at creating an immune response in patients and could help lower cancer biomarkers. The vaccine won't have to be customized to each patient, making it more readily available and less expensive. Larger studies are needed to confirm its efficacy.

health3 years ago

New Cancer Vaccine Shows Promise in Treating Deadliest Forms: Study

An off-the-shelf cancer vaccine has shown potential to prevent relapse in patients with pancreatic and colon cancer caused by the KRAS mutation, which accounts for up to 90% of the disease. The vaccine uses peptides to bind to the protein albumin, creating white blood cells that help fight off cancer markers present in the patients’ blood. The vaccine was 100% effective at creating an immune response in patients and could help lower cancer biomarkers. The vaccine won't have to be customized to each patient, making it more readily available and less expensive. Larger studies are needed to confirm its efficacy.

New Cancer Vaccine Shows Promise in Treating Deadly Forms and Preventing Relapse
health3 years ago

New Cancer Vaccine Shows Promise in Treating Deadly Forms and Preventing Relapse

An off-the-shelf cancer vaccine developed by Elicio Therapeutics has shown potential to lower the risk of relapse in patients with colon and pancreatic cancers caused by the KRAS mutation, which accounts for up to 90% of cases. In an early trial, the vaccine was found to be safe and feasible, and could improve survival rates for these two deadly cancers. Unlike other experimental cancer vaccines, this vaccine does not need to be customized to each patient, making it more readily available and less expensive. The vaccine uses peptides to bind to the protein albumin, which then travels to the lymph nodes and creates white blood cells to fight off cancer markers found in the patients' blood.